Bulevirtide

Bulevirtide is a novel virion entry inhibitor which blocks the virion's hepatocyte pathway of entry, the hepatic sodium/taurocholate cotransporting polypeptide (NTCP) receptor, and is now a promising therapy for both infections.


Cat. No.: EX-A7414	Purity: >98%

	Chemical structure of Bulevirtide

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	700	In-stock
50mg	1100	In-stock
100mg	1700	In-stock
250mg	2500	In-stock
500mg	3600	In-stock
1g	4800	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	Myrcludex B
CAS No.	2012558-47-1
Purity	>98%
Formula	C248H355N65O72
Mol Weight	5398.8647
Color	White to off-white
State	solid powder
Solubility	H2O : 83.33 mg/mL DMSO : 50 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -80℃ 3 years; Powder -20℃ 2 years;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Urban, Stephan et al. “Strategies to inhibit entry of HBV and HDV into hepatocytes.” Gastroenterology vol. 147,1 (2014): 48-64. doi:10.1053/j.gastro.2014.04.030 [2]. Donkers, Joanne M et al. “Mechanistic insights into the inhibition of NTCP by myrcludex B.” JHEP reports : innovation in hepatology vol. 1,4 278-285. 1 Aug. 2019, doi:10.1016/j.jhepr.2019.07.006 [3]. Yardeni, D, and C Koh. “Bulevirtide for HBV and HDV infections.” Drugs of today (Barcelona, Spain : 1998) vol. 57,7 (2021): 433-448. doi:10.1358/dot.2021.57.7.3283861
Data Sheet	Data sheet of Bulevirtide
CoA	CoA of Bulevirtide
SDS	SDS of Bulevirtide


		Search